nodes	percent_of_prediction	percent_of_DWPC	metapath
Vincristine—ABCC10—Estradiol—osteoporosis	0.0874	0.137	CbGbCtD
Vincristine—ABCB11—Ethinyl Estradiol—osteoporosis	0.0737	0.115	CbGbCtD
Vincristine—ABCC1—Zoledronate—osteoporosis	0.0691	0.108	CbGbCtD
Vincristine—ABCC3—Conjugated Estrogens—osteoporosis	0.0626	0.0979	CbGbCtD
Vincristine—SLC22A3—Estradiol—osteoporosis	0.0517	0.0808	CbGbCtD
Vincristine—ABCC2—Ethinyl Estradiol—osteoporosis	0.0387	0.0606	CbGbCtD
Vincristine—ABCC1—Conjugated Estrogens—osteoporosis	0.0384	0.0601	CbGbCtD
Vincristine—ABCC2—Conjugated Estrogens—osteoporosis	0.0284	0.0445	CbGbCtD
Vincristine—ABCG2—Conjugated Estrogens—osteoporosis	0.0257	0.0402	CbGbCtD
Vincristine—ABCG2—Estradiol—osteoporosis	0.0226	0.0353	CbGbCtD
Vincristine—CYP3A7—Estradiol—osteoporosis	0.0167	0.0261	CbGbCtD
Vincristine—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0167	0.0261	CbGbCtD
Vincristine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0126	0.0198	CbGbCtD
Vincristine—CYP3A5—Estradiol—osteoporosis	0.0125	0.0196	CbGbCtD
Vincristine—CYP3A4—Calcitriol—osteoporosis	0.0117	0.0184	CbGbCtD
Vincristine—CYP3A4—Estropipate—osteoporosis	0.0117	0.0184	CbGbCtD
Vincristine—CYP3A4—Ergocalciferol—osteoporosis	0.00939	0.0147	CbGbCtD
Vincristine—ABCB1—Conjugated Estrogens—osteoporosis	0.00927	0.0145	CbGbCtD
Vincristine—ABCB1—Estradiol—osteoporosis	0.00814	0.0127	CbGbCtD
Vincristine—CYP3A4—Raloxifene—osteoporosis	0.00783	0.0123	CbGbCtD
Vincristine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00757	0.0118	CbGbCtD
Vincristine—CYP3A4—Cholecalciferol—osteoporosis	0.00605	0.00947	CbGbCtD
Vincristine—CYP3A4—Conjugated Estrogens—osteoporosis	0.00555	0.00869	CbGbCtD
Vincristine—CYP3A4—Estradiol—osteoporosis	0.00488	0.00763	CbGbCtD
Vincristine—TUBB6—Fulvestrant—Estradiol—osteoporosis	0.00118	0.602	CbGdCrCtD
Vincristine—TUBB6—Levorphanol—Estradiol—osteoporosis	0.000778	0.398	CbGdCrCtD
Vincristine—Leukopenia—Pamidronate—osteoporosis	0.00025	0.00143	CcSEcCtD
Vincristine—Alopecia—Conjugated Estrogens—osteoporosis	0.000249	0.00142	CcSEcCtD
Vincristine—Pain—Ibandronate—osteoporosis	0.000249	0.00142	CcSEcCtD
Vincristine—Constipation—Ibandronate—osteoporosis	0.000249	0.00142	CcSEcCtD
Vincristine—Gastrointestinal pain—Estropipate—osteoporosis	0.000248	0.00142	CcSEcCtD
Vincristine—Acute coronary syndrome—Estradiol—osteoporosis	0.000248	0.00142	CcSEcCtD
Vincristine—Decreased appetite—Calcitriol—osteoporosis	0.000248	0.00141	CcSEcCtD
Vincristine—Mental disorder—Conjugated Estrogens—osteoporosis	0.000247	0.00141	CcSEcCtD
Vincristine—Back pain—Zoledronate—osteoporosis	0.000247	0.00141	CcSEcCtD
Vincristine—Neuropathy peripheral—Estradiol—osteoporosis	0.000247	0.00141	CcSEcCtD
Vincristine—Myocardial infarction—Estradiol—osteoporosis	0.000247	0.00141	CcSEcCtD
Vincristine—Oedema—Ethinyl Estradiol—osteoporosis	0.000246	0.0014	CcSEcCtD
Vincristine—Gastrointestinal pain—Alendronate—osteoporosis	0.000244	0.0014	CcSEcCtD
Vincristine—Infection—Ethinyl Estradiol—osteoporosis	0.000244	0.00139	CcSEcCtD
Vincristine—Constipation—Calcitriol—osteoporosis	0.000244	0.00139	CcSEcCtD
Vincristine—Pain—Calcitriol—osteoporosis	0.000244	0.00139	CcSEcCtD
Vincristine—Convulsion—Pamidronate—osteoporosis	0.000242	0.00138	CcSEcCtD
Vincristine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000241	0.00138	CcSEcCtD
Vincristine—Hypertension—Pamidronate—osteoporosis	0.000241	0.00138	CcSEcCtD
Vincristine—Gastrointestinal pain—Raloxifene—osteoporosis	0.00024	0.00137	CcSEcCtD
Vincristine—Diarrhoea—Etidronic acid—osteoporosis	0.00024	0.00137	CcSEcCtD
Vincristine—Abdominal pain—Estropipate—osteoporosis	0.00024	0.00137	CcSEcCtD
Vincristine—Body temperature increased—Estropipate—osteoporosis	0.00024	0.00137	CcSEcCtD
Vincristine—Infection—Risedronate—osteoporosis	0.000238	0.00136	CcSEcCtD
Vincristine—Gastrointestinal pain—Ibandronate—osteoporosis	0.000238	0.00136	CcSEcCtD
Vincristine—Myalgia—Pamidronate—osteoporosis	0.000238	0.00136	CcSEcCtD
Vincristine—Back pain—Conjugated Estrogens—osteoporosis	0.000238	0.00136	CcSEcCtD
Vincristine—Abdominal pain—Alendronate—osteoporosis	0.000236	0.00135	CcSEcCtD
Vincristine—Body temperature increased—Alendronate—osteoporosis	0.000236	0.00135	CcSEcCtD
Vincristine—Anaemia—Zoledronate—osteoporosis	0.000236	0.00135	CcSEcCtD
Vincristine—Nervous system disorder—Risedronate—osteoporosis	0.000235	0.00134	CcSEcCtD
Vincristine—Agitation—Zoledronate—osteoporosis	0.000235	0.00134	CcSEcCtD
Vincristine—Gastrointestinal pain—Calcitriol—osteoporosis	0.000233	0.00133	CcSEcCtD
Vincristine—Body temperature increased—Raloxifene—osteoporosis	0.000232	0.00133	CcSEcCtD
Vincristine—Abdominal pain—Raloxifene—osteoporosis	0.000232	0.00133	CcSEcCtD
Vincristine—Body temperature increased—Ibandronate—osteoporosis	0.00023	0.00131	CcSEcCtD
Vincristine—Abdominal pain—Ibandronate—osteoporosis	0.00023	0.00131	CcSEcCtD
Vincristine—Vertigo—Zoledronate—osteoporosis	0.000229	0.00131	CcSEcCtD
Vincristine—Leukopenia—Zoledronate—osteoporosis	0.000228	0.0013	CcSEcCtD
Vincristine—Oedema—Pamidronate—osteoporosis	0.000228	0.0013	CcSEcCtD
Vincristine—Anaphylactic shock—Pamidronate—osteoporosis	0.000228	0.0013	CcSEcCtD
Vincristine—Infection—Pamidronate—osteoporosis	0.000227	0.00129	CcSEcCtD
Vincristine—Abdominal pain—Calcitriol—osteoporosis	0.000225	0.00129	CcSEcCtD
Vincristine—Body temperature increased—Calcitriol—osteoporosis	0.000225	0.00129	CcSEcCtD
Vincristine—Hypoaesthesia—Estradiol—osteoporosis	0.000225	0.00128	CcSEcCtD
Vincristine—Hypersensitivity—Estropipate—osteoporosis	0.000224	0.00128	CcSEcCtD
Vincristine—Nervous system disorder—Pamidronate—osteoporosis	0.000224	0.00128	CcSEcCtD
Vincristine—Thrombocytopenia—Pamidronate—osteoporosis	0.000223	0.00127	CcSEcCtD
Vincristine—Urinary tract disorder—Estradiol—osteoporosis	0.000223	0.00127	CcSEcCtD
Vincristine—Vomiting—Etidronic acid—osteoporosis	0.000223	0.00127	CcSEcCtD
Vincristine—Connective tissue disorder—Estradiol—osteoporosis	0.000222	0.00127	CcSEcCtD
Vincristine—Urethral disorder—Estradiol—osteoporosis	0.000221	0.00126	CcSEcCtD
Vincristine—Rash—Etidronic acid—osteoporosis	0.000221	0.00126	CcSEcCtD
Vincristine—Convulsion—Zoledronate—osteoporosis	0.000221	0.00126	CcSEcCtD
Vincristine—Dermatitis—Etidronic acid—osteoporosis	0.000221	0.00126	CcSEcCtD
Vincristine—Vertigo—Conjugated Estrogens—osteoporosis	0.000221	0.00126	CcSEcCtD
Vincristine—Hyperhidrosis—Pamidronate—osteoporosis	0.00022	0.00126	CcSEcCtD
Vincristine—Hypertension—Zoledronate—osteoporosis	0.00022	0.00126	CcSEcCtD
Vincristine—Hypersensitivity—Alendronate—osteoporosis	0.00022	0.00126	CcSEcCtD
Vincristine—Headache—Etidronic acid—osteoporosis	0.00022	0.00125	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000219	0.00125	CcSEcCtD
Vincristine—Asthenia—Estropipate—osteoporosis	0.000218	0.00124	CcSEcCtD
Vincristine—Anorexia—Pamidronate—osteoporosis	0.000217	0.00124	CcSEcCtD
Vincristine—Myalgia—Zoledronate—osteoporosis	0.000217	0.00124	CcSEcCtD
Vincristine—Insomnia—Risedronate—osteoporosis	0.000217	0.00124	CcSEcCtD
Vincristine—Paraesthesia—Risedronate—osteoporosis	0.000215	0.00123	CcSEcCtD
Vincristine—Asthenia—Alendronate—osteoporosis	0.000215	0.00122	CcSEcCtD
Vincristine—Hypersensitivity—Ibandronate—osteoporosis	0.000214	0.00122	CcSEcCtD
Vincristine—Hypotension—Pamidronate—osteoporosis	0.000213	0.00122	CcSEcCtD
Vincristine—Convulsion—Conjugated Estrogens—osteoporosis	0.000213	0.00122	CcSEcCtD
Vincristine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000212	0.00121	CcSEcCtD
Vincristine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000212	0.00121	CcSEcCtD
Vincristine—Constipation—Ethinyl Estradiol—osteoporosis	0.00021	0.0012	CcSEcCtD
Vincristine—Hypersensitivity—Calcitriol—osteoporosis	0.00021	0.0012	CcSEcCtD
Vincristine—Cardiac disorder—Estradiol—osteoporosis	0.00021	0.0012	CcSEcCtD
Vincristine—Myalgia—Conjugated Estrogens—osteoporosis	0.000209	0.00119	CcSEcCtD
Vincristine—Asthenia—Ibandronate—osteoporosis	0.000209	0.00119	CcSEcCtD
Vincristine—Nausea—Etidronic acid—osteoporosis	0.000208	0.00119	CcSEcCtD
Vincristine—Anaphylactic shock—Zoledronate—osteoporosis	0.000208	0.00119	CcSEcCtD
Vincristine—Oedema—Zoledronate—osteoporosis	0.000208	0.00119	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000208	0.00119	CcSEcCtD
Vincristine—Diarrhoea—Estropipate—osteoporosis	0.000208	0.00119	CcSEcCtD
Vincristine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000207	0.00118	CcSEcCtD
Vincristine—Infection—Zoledronate—osteoporosis	0.000207	0.00118	CcSEcCtD
Vincristine—Fatigue—Risedronate—osteoporosis	0.000207	0.00118	CcSEcCtD
Vincristine—Insomnia—Pamidronate—osteoporosis	0.000206	0.00118	CcSEcCtD
Vincristine—Pain—Risedronate—osteoporosis	0.000205	0.00117	CcSEcCtD
Vincristine—Constipation—Risedronate—osteoporosis	0.000205	0.00117	CcSEcCtD
Vincristine—Angiopathy—Estradiol—osteoporosis	0.000205	0.00117	CcSEcCtD
Vincristine—Paraesthesia—Pamidronate—osteoporosis	0.000205	0.00117	CcSEcCtD
Vincristine—Diarrhoea—Alendronate—osteoporosis	0.000205	0.00117	CcSEcCtD
Vincristine—Asthenia—Calcitriol—osteoporosis	0.000204	0.00117	CcSEcCtD
Vincristine—Nervous system disorder—Zoledronate—osteoporosis	0.000204	0.00117	CcSEcCtD
Vincristine—Thrombocytopenia—Zoledronate—osteoporosis	0.000204	0.00116	CcSEcCtD
Vincristine—Mediastinal disorder—Estradiol—osteoporosis	0.000204	0.00116	CcSEcCtD
Vincristine—Hyperhidrosis—Zoledronate—osteoporosis	0.000201	0.00115	CcSEcCtD
Vincristine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000201	0.00115	CcSEcCtD
Vincristine—Diarrhoea—Raloxifene—osteoporosis	0.000201	0.00115	CcSEcCtD
Vincristine—Dizziness—Estropipate—osteoporosis	0.000201	0.00115	CcSEcCtD
Vincristine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000201	0.00114	CcSEcCtD
Vincristine—Oedema—Conjugated Estrogens—osteoporosis	0.000201	0.00114	CcSEcCtD
Vincristine—Alopecia—Estradiol—osteoporosis	0.0002	0.00114	CcSEcCtD
Vincristine—Infection—Conjugated Estrogens—osteoporosis	0.000199	0.00114	CcSEcCtD
Vincristine—Diarrhoea—Ibandronate—osteoporosis	0.000199	0.00114	CcSEcCtD
Vincristine—Anorexia—Zoledronate—osteoporosis	0.000199	0.00113	CcSEcCtD
Vincristine—Decreased appetite—Pamidronate—osteoporosis	0.000198	0.00113	CcSEcCtD
Vincristine—Mental disorder—Estradiol—osteoporosis	0.000198	0.00113	CcSEcCtD
Vincristine—Dizziness—Alendronate—osteoporosis	0.000198	0.00113	CcSEcCtD
Vincristine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000197	0.00112	CcSEcCtD
Vincristine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000197	0.00112	CcSEcCtD
Vincristine—Fatigue—Pamidronate—osteoporosis	0.000197	0.00112	CcSEcCtD
Vincristine—Gastrointestinal pain—Risedronate—osteoporosis	0.000196	0.00112	CcSEcCtD
Vincristine—Pain—Pamidronate—osteoporosis	0.000195	0.00111	CcSEcCtD
Vincristine—Constipation—Pamidronate—osteoporosis	0.000195	0.00111	CcSEcCtD
Vincristine—Diarrhoea—Calcitriol—osteoporosis	0.000195	0.00111	CcSEcCtD
Vincristine—Hypotension—Zoledronate—osteoporosis	0.000195	0.00111	CcSEcCtD
Vincristine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000195	0.00111	CcSEcCtD
Vincristine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000195	0.00111	CcSEcCtD
Vincristine—Dizziness—Raloxifene—osteoporosis	0.000194	0.00111	CcSEcCtD
Vincristine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000194	0.00111	CcSEcCtD
Vincristine—Vomiting—Estropipate—osteoporosis	0.000193	0.0011	CcSEcCtD
Vincristine—Dizziness—Ibandronate—osteoporosis	0.000192	0.0011	CcSEcCtD
Vincristine—Rash—Estropipate—osteoporosis	0.000191	0.00109	CcSEcCtD
Vincristine—Dermatitis—Estropipate—osteoporosis	0.000191	0.00109	CcSEcCtD
Vincristine—Anorexia—Conjugated Estrogens—osteoporosis	0.000191	0.00109	CcSEcCtD
Vincristine—Back pain—Estradiol—osteoporosis	0.00019	0.00109	CcSEcCtD
Vincristine—Headache—Estropipate—osteoporosis	0.00019	0.00109	CcSEcCtD
Vincristine—Vomiting—Alendronate—osteoporosis	0.00019	0.00108	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00019	0.00108	CcSEcCtD
Vincristine—Body temperature increased—Risedronate—osteoporosis	0.00019	0.00108	CcSEcCtD
Vincristine—Abdominal pain—Risedronate—osteoporosis	0.00019	0.00108	CcSEcCtD
Vincristine—Rash—Alendronate—osteoporosis	0.000189	0.00108	CcSEcCtD
Vincristine—Insomnia—Zoledronate—osteoporosis	0.000188	0.00108	CcSEcCtD
Vincristine—Dermatitis—Alendronate—osteoporosis	0.000188	0.00107	CcSEcCtD
Vincristine—Hypotension—Conjugated Estrogens—osteoporosis	0.000187	0.00107	CcSEcCtD
Vincristine—Headache—Alendronate—osteoporosis	0.000187	0.00107	CcSEcCtD
Vincristine—Paraesthesia—Zoledronate—osteoporosis	0.000187	0.00107	CcSEcCtD
Vincristine—Vomiting—Raloxifene—osteoporosis	0.000187	0.00107	CcSEcCtD
Vincristine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000186	0.00106	CcSEcCtD
Vincristine—Rash—Raloxifene—osteoporosis	0.000185	0.00106	CcSEcCtD
Vincristine—Dermatitis—Raloxifene—osteoporosis	0.000185	0.00106	CcSEcCtD
Vincristine—Vomiting—Ibandronate—osteoporosis	0.000185	0.00106	CcSEcCtD
Vincristine—Headache—Raloxifene—osteoporosis	0.000184	0.00105	CcSEcCtD
Vincristine—Rash—Ibandronate—osteoporosis	0.000184	0.00105	CcSEcCtD
Vincristine—Dermatitis—Ibandronate—osteoporosis	0.000183	0.00105	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000183	0.00104	CcSEcCtD
Vincristine—Headache—Ibandronate—osteoporosis	0.000182	0.00104	CcSEcCtD
Vincristine—Insomnia—Conjugated Estrogens—osteoporosis	0.000181	0.00104	CcSEcCtD
Vincristine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000181	0.00103	CcSEcCtD
Vincristine—Vomiting—Calcitriol—osteoporosis	0.000181	0.00103	CcSEcCtD
Vincristine—Decreased appetite—Zoledronate—osteoporosis	0.000181	0.00103	CcSEcCtD
Vincristine—Agitation—Estradiol—osteoporosis	0.000181	0.00103	CcSEcCtD
Vincristine—Nausea—Estropipate—osteoporosis	0.00018	0.00103	CcSEcCtD
Vincristine—Abdominal pain—Pamidronate—osteoporosis	0.00018	0.00103	CcSEcCtD
Vincristine—Body temperature increased—Pamidronate—osteoporosis	0.00018	0.00103	CcSEcCtD
Vincristine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00018	0.00103	CcSEcCtD
Vincristine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00018	0.00103	CcSEcCtD
Vincristine—Rash—Calcitriol—osteoporosis	0.00018	0.00103	CcSEcCtD
Vincristine—Fatigue—Zoledronate—osteoporosis	0.00018	0.00102	CcSEcCtD
Vincristine—Dermatitis—Calcitriol—osteoporosis	0.00018	0.00102	CcSEcCtD
Vincristine—Headache—Calcitriol—osteoporosis	0.000179	0.00102	CcSEcCtD
Vincristine—Pain—Zoledronate—osteoporosis	0.000178	0.00102	CcSEcCtD
Vincristine—Constipation—Zoledronate—osteoporosis	0.000178	0.00102	CcSEcCtD
Vincristine—Nausea—Alendronate—osteoporosis	0.000178	0.00101	CcSEcCtD
Vincristine—Hypersensitivity—Risedronate—osteoporosis	0.000177	0.00101	CcSEcCtD
Vincristine—Vertigo—Estradiol—osteoporosis	0.000177	0.00101	CcSEcCtD
Vincristine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000177	0.00101	CcSEcCtD
Vincristine—Nausea—Raloxifene—osteoporosis	0.000175	0.000997	CcSEcCtD
Vincristine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000174	0.000995	CcSEcCtD
Vincristine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000173	0.000988	CcSEcCtD
Vincristine—Fatigue—Conjugated Estrogens—osteoporosis	0.000173	0.000987	CcSEcCtD
Vincristine—Nausea—Ibandronate—osteoporosis	0.000173	0.000987	CcSEcCtD
Vincristine—Asthenia—Risedronate—osteoporosis	0.000172	0.000982	CcSEcCtD
Vincristine—Pain—Conjugated Estrogens—osteoporosis	0.000172	0.000979	CcSEcCtD
Vincristine—Constipation—Conjugated Estrogens—osteoporosis	0.000172	0.000979	CcSEcCtD
Vincristine—Gastrointestinal pain—Zoledronate—osteoporosis	0.00017	0.000972	CcSEcCtD
Vincristine—Hypertension—Estradiol—osteoporosis	0.00017	0.000969	CcSEcCtD
Vincristine—Nausea—Calcitriol—osteoporosis	0.000169	0.000966	CcSEcCtD
Vincristine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000168	0.000961	CcSEcCtD
Vincristine—Hypersensitivity—Pamidronate—osteoporosis	0.000168	0.000959	CcSEcCtD
Vincristine—Myalgia—Estradiol—osteoporosis	0.000167	0.000956	CcSEcCtD
Vincristine—Abdominal pain—Zoledronate—osteoporosis	0.000165	0.00094	CcSEcCtD
Vincristine—Body temperature increased—Zoledronate—osteoporosis	0.000165	0.00094	CcSEcCtD
Vincristine—Diarrhoea—Risedronate—osteoporosis	0.000164	0.000937	CcSEcCtD
Vincristine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000164	0.000936	CcSEcCtD
Vincristine—Asthenia—Pamidronate—osteoporosis	0.000164	0.000934	CcSEcCtD
Vincristine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000163	0.000928	CcSEcCtD
Vincristine—Anaphylactic shock—Estradiol—osteoporosis	0.000161	0.000916	CcSEcCtD
Vincristine—Oedema—Estradiol—osteoporosis	0.000161	0.000916	CcSEcCtD
Vincristine—Infection—Estradiol—osteoporosis	0.000159	0.00091	CcSEcCtD
Vincristine—Dizziness—Risedronate—osteoporosis	0.000159	0.000905	CcSEcCtD
Vincristine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000159	0.000905	CcSEcCtD
Vincristine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000159	0.000905	CcSEcCtD
Vincristine—Nervous system disorder—Estradiol—osteoporosis	0.000157	0.000898	CcSEcCtD
Vincristine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000156	0.000893	CcSEcCtD
Vincristine—Diarrhoea—Pamidronate—osteoporosis	0.000156	0.00089	CcSEcCtD
Vincristine—Hyperhidrosis—Estradiol—osteoporosis	0.000155	0.000886	CcSEcCtD
Vincristine—Rash—Ethinyl Estradiol—osteoporosis	0.000155	0.000885	CcSEcCtD
Vincristine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000155	0.000884	CcSEcCtD
Vincristine—Headache—Ethinyl Estradiol—osteoporosis	0.000154	0.00088	CcSEcCtD
Vincristine—Hypersensitivity—Zoledronate—osteoporosis	0.000153	0.000876	CcSEcCtD
Vincristine—Vomiting—Risedronate—osteoporosis	0.000153	0.00087	CcSEcCtD
Vincristine—Rash—Risedronate—osteoporosis	0.000151	0.000863	CcSEcCtD
Vincristine—Dermatitis—Risedronate—osteoporosis	0.000151	0.000862	CcSEcCtD
Vincristine—Dizziness—Pamidronate—osteoporosis	0.000151	0.000861	CcSEcCtD
Vincristine—Headache—Risedronate—osteoporosis	0.00015	0.000858	CcSEcCtD
Vincristine—Asthenia—Zoledronate—osteoporosis	0.000149	0.000853	CcSEcCtD
Vincristine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000148	0.000843	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000146	0.000835	CcSEcCtD
Vincristine—Nausea—Ethinyl Estradiol—osteoporosis	0.000146	0.000834	CcSEcCtD
Vincristine—Insomnia—Estradiol—osteoporosis	0.000145	0.000829	CcSEcCtD
Vincristine—Vomiting—Pamidronate—osteoporosis	0.000145	0.000827	CcSEcCtD
Vincristine—Paraesthesia—Estradiol—osteoporosis	0.000144	0.000823	CcSEcCtD
Vincristine—Asthenia—Conjugated Estrogens—osteoporosis	0.000144	0.000821	CcSEcCtD
Vincristine—Rash—Pamidronate—osteoporosis	0.000144	0.000821	CcSEcCtD
Vincristine—Dermatitis—Pamidronate—osteoporosis	0.000144	0.00082	CcSEcCtD
Vincristine—Headache—Pamidronate—osteoporosis	0.000143	0.000815	CcSEcCtD
Vincristine—Diarrhoea—Zoledronate—osteoporosis	0.000143	0.000813	CcSEcCtD
Vincristine—Nausea—Risedronate—osteoporosis	0.000142	0.000813	CcSEcCtD
Vincristine—Decreased appetite—Estradiol—osteoporosis	0.00014	0.000796	CcSEcCtD
Vincristine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000139	0.000791	CcSEcCtD
Vincristine—Fatigue—Estradiol—osteoporosis	0.000138	0.00079	CcSEcCtD
Vincristine—Dizziness—Zoledronate—osteoporosis	0.000138	0.000786	CcSEcCtD
Vincristine—Constipation—Estradiol—osteoporosis	0.000137	0.000783	CcSEcCtD
Vincristine—Pain—Estradiol—osteoporosis	0.000137	0.000783	CcSEcCtD
Vincristine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000137	0.000783	CcSEcCtD
Vincristine—Nausea—Pamidronate—osteoporosis	0.000135	0.000773	CcSEcCtD
Vincristine—Dizziness—Conjugated Estrogens—osteoporosis	0.000133	0.000757	CcSEcCtD
Vincristine—Vomiting—Zoledronate—osteoporosis	0.000132	0.000756	CcSEcCtD
Vincristine—Rash—Zoledronate—osteoporosis	0.000131	0.000749	CcSEcCtD
Vincristine—Gastrointestinal pain—Estradiol—osteoporosis	0.000131	0.000749	CcSEcCtD
Vincristine—Dermatitis—Zoledronate—osteoporosis	0.000131	0.000749	CcSEcCtD
Vincristine—Headache—Zoledronate—osteoporosis	0.00013	0.000745	CcSEcCtD
Vincristine—Vomiting—Conjugated Estrogens—osteoporosis	0.000128	0.000728	CcSEcCtD
Vincristine—Abdominal pain—Estradiol—osteoporosis	0.000127	0.000724	CcSEcCtD
Vincristine—Body temperature increased—Estradiol—osteoporosis	0.000127	0.000724	CcSEcCtD
Vincristine—Rash—Conjugated Estrogens—osteoporosis	0.000126	0.000722	CcSEcCtD
Vincristine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000126	0.000721	CcSEcCtD
Vincristine—Headache—Conjugated Estrogens—osteoporosis	0.000126	0.000717	CcSEcCtD
Vincristine—Nausea—Zoledronate—osteoporosis	0.000124	0.000706	CcSEcCtD
Vincristine—Nausea—Conjugated Estrogens—osteoporosis	0.000119	0.00068	CcSEcCtD
Vincristine—Hypersensitivity—Estradiol—osteoporosis	0.000118	0.000675	CcSEcCtD
Vincristine—Asthenia—Estradiol—osteoporosis	0.000115	0.000657	CcSEcCtD
Vincristine—Diarrhoea—Estradiol—osteoporosis	0.00011	0.000627	CcSEcCtD
Vincristine—Dizziness—Estradiol—osteoporosis	0.000106	0.000606	CcSEcCtD
Vincristine—Vomiting—Estradiol—osteoporosis	0.000102	0.000582	CcSEcCtD
Vincristine—Rash—Estradiol—osteoporosis	0.000101	0.000578	CcSEcCtD
Vincristine—Dermatitis—Estradiol—osteoporosis	0.000101	0.000577	CcSEcCtD
Vincristine—Headache—Estradiol—osteoporosis	0.000101	0.000574	CcSEcCtD
Vincristine—Nausea—Estradiol—osteoporosis	9.54e-05	0.000544	CcSEcCtD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.41e-05	0.000131	CbGpPWpGaD
Vincristine—TUBB6—Metabolism of proteins—POMC—osteoporosis	2.41e-05	0.000131	CbGpPWpGaD
Vincristine—TUBB2B—Metabolism of proteins—POMC—osteoporosis	2.41e-05	0.000131	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—CYP27A1—osteoporosis	2.41e-05	0.000131	CbGpPWpGaD
Vincristine—SLC22A3—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.4e-05	0.000131	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—ADCY5—osteoporosis	2.38e-05	0.000129	CbGpPWpGaD
Vincristine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.37e-05	0.000129	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—TPI1—osteoporosis	2.37e-05	0.000129	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—MGLL—osteoporosis	2.36e-05	0.000129	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—ACP5—osteoporosis	2.34e-05	0.000128	CbGpPWpGaD
Vincristine—TUBB3—Metabolism of proteins—POMC—osteoporosis	2.33e-05	0.000127	CbGpPWpGaD
Vincristine—TUBB6—Metabolism of proteins—IGF1—osteoporosis	2.32e-05	0.000126	CbGpPWpGaD
Vincristine—TUBB2B—Metabolism of proteins—IGF1—osteoporosis	2.32e-05	0.000126	CbGpPWpGaD
Vincristine—ABCC2—NRF2 pathway—TGFB1—osteoporosis	2.32e-05	0.000126	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.32e-05	0.000126	CbGpPWpGaD
Vincristine—TUBB4A—Metabolism of proteins—LEP—osteoporosis	2.31e-05	0.000125	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—SPP1—osteoporosis	2.3e-05	0.000125	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—IL1B—osteoporosis	2.29e-05	0.000125	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—TPI1—osteoporosis	2.27e-05	0.000124	CbGpPWpGaD
Vincristine—TUBB2A—Metabolism of proteins—POMC—osteoporosis	2.26e-05	0.000123	CbGpPWpGaD
Vincristine—TUBB3—Metabolism of proteins—IGF1—osteoporosis	2.24e-05	0.000122	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—P4HB—osteoporosis	2.23e-05	0.000121	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.23e-05	0.000121	CbGpPWpGaD
Vincristine—ABCC3—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.21e-05	0.00012	CbGpPWpGaD
Vincristine—TUBB1—Metabolism of proteins—POMC—osteoporosis	2.21e-05	0.00012	CbGpPWpGaD
Vincristine—CYP3A5—Biological oxidations—POMC—osteoporosis	2.2e-05	0.00012	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	2.19e-05	0.000119	CbGpPWpGaD
Vincristine—ABCC1—Disease—ACP5—osteoporosis	2.19e-05	0.000119	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—GAPDH—osteoporosis	2.19e-05	0.000119	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—TPI1—osteoporosis	2.18e-05	0.000119	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—MYC—osteoporosis	2.18e-05	0.000119	CbGpPWpGaD
Vincristine—TUBB2A—Metabolism of proteins—IGF1—osteoporosis	2.17e-05	0.000118	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—P4HB—osteoporosis	2.14e-05	0.000116	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—OXCT1—osteoporosis	2.13e-05	0.000116	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—CA2—osteoporosis	2.13e-05	0.000116	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—RAP1A—osteoporosis	2.13e-05	0.000116	CbGpPWpGaD
Vincristine—TUBB1—Metabolism of proteins—IGF1—osteoporosis	2.12e-05	0.000115	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—CA2—osteoporosis	2.11e-05	0.000115	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—OXCT1—osteoporosis	2.11e-05	0.000115	CbGpPWpGaD
Vincristine—TUBB4B—Metabolism of proteins—LEP—osteoporosis	2.11e-05	0.000115	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—GAPDH—osteoporosis	2.1e-05	0.000114	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—MGLL—osteoporosis	2.08e-05	0.000113	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—IRS2—osteoporosis	2.08e-05	0.000113	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PKM—osteoporosis	2.07e-05	0.000113	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—FDPS—osteoporosis	2.07e-05	0.000113	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—MGLL—osteoporosis	2.06e-05	0.000112	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—TGFB1—osteoporosis	2.06e-05	0.000112	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—P4HB—osteoporosis	2.05e-05	0.000112	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—RAP1A—osteoporosis	2.04e-05	0.000111	CbGpPWpGaD
Vincristine—ABCC1—Disease—TPI1—osteoporosis	2.04e-05	0.000111	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—LEP—osteoporosis	2.03e-05	0.000111	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—GAPDH—osteoporosis	2.01e-05	0.000109	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—IDH2—osteoporosis	2.01e-05	0.000109	CbGpPWpGaD
Vincristine—TUBB4A—Metabolism of proteins—POMC—osteoporosis	1.98e-05	0.000108	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—GPD2—osteoporosis	1.97e-05	0.000107	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PGLS—osteoporosis	1.97e-05	0.000107	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—RAP1A—osteoporosis	1.96e-05	0.000107	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—MYC—osteoporosis	1.95e-05	0.000106	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—ESR1—osteoporosis	1.94e-05	0.000106	CbGpPWpGaD
Vincristine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.92e-05	0.000105	CbGpPWpGaD
Vincristine—ABCC1—Disease—P4HB—osteoporosis	1.92e-05	0.000104	CbGpPWpGaD
Vincristine—TUBB4A—Metabolism of proteins—IGF1—osteoporosis	1.9e-05	0.000104	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—CYP27A1—osteoporosis	1.89e-05	0.000103	CbGpPWpGaD
Vincristine—ABCC1—Disease—GAPDH—osteoporosis	1.88e-05	0.000102	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—MYC—osteoporosis	1.85e-05	0.000101	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—ACP5—osteoporosis	1.84e-05	0.0001	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—IRS1—osteoporosis	1.81e-05	9.87e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.81e-05	9.87e-05	CbGpPWpGaD
Vincristine—TUBB4B—Metabolism of proteins—POMC—osteoporosis	1.81e-05	9.85e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ATIC—osteoporosis	1.8e-05	9.78e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PNP—osteoporosis	1.8e-05	9.78e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—NFATC1—osteoporosis	1.79e-05	9.73e-05	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—TGFB1—osteoporosis	1.78e-05	9.7e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.78e-05	9.7e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—DKK1—osteoporosis	1.77e-05	9.65e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—IDH2—osteoporosis	1.77e-05	9.62e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—IDH2—osteoporosis	1.75e-05	9.53e-05	CbGpPWpGaD
Vincristine—ABCC2—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.75e-05	9.53e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—POMC—osteoporosis	1.75e-05	9.51e-05	CbGpPWpGaD
Vincristine—TUBB4B—Metabolism of proteins—IGF1—osteoporosis	1.74e-05	9.48e-05	CbGpPWpGaD
Vincristine—ABCC1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.73e-05	9.42e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—ENO1—osteoporosis	1.72e-05	9.38e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—WNT1—osteoporosis	1.71e-05	9.3e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.71e-05	9.3e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—TPI1—osteoporosis	1.71e-05	9.29e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—IL6R—osteoporosis	1.7e-05	9.27e-05	CbGpPWpGaD
Vincristine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.7e-05	9.25e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PSMA5—osteoporosis	1.7e-05	9.24e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PSMA2—osteoporosis	1.7e-05	9.24e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.7e-05	9.22e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—IGF1—osteoporosis	1.68e-05	9.15e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.68e-05	9.12e-05	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—TNF—osteoporosis	1.66e-05	9.06e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—FGA—osteoporosis	1.66e-05	9.05e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—CYP27A1—osteoporosis	1.66e-05	9.04e-05	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—MYC—osteoporosis	1.66e-05	9.02e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—ENO1—osteoporosis	1.65e-05	8.99e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—CYP27A1—osteoporosis	1.65e-05	8.96e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PSMA2—osteoporosis	1.63e-05	8.86e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PSMA5—osteoporosis	1.63e-05	8.86e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—ACP5—osteoporosis	1.62e-05	8.8e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—P4HB—osteoporosis	1.61e-05	8.74e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—ACP5—osteoporosis	1.6e-05	8.72e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—ENO1—osteoporosis	1.58e-05	8.62e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—GAPDH—osteoporosis	1.58e-05	8.58e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—FDPS—osteoporosis	1.56e-05	8.51e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PKM—osteoporosis	1.56e-05	8.51e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PSMA2—osteoporosis	1.56e-05	8.49e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PSMA5—osteoporosis	1.56e-05	8.49e-05	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—MYC—osteoporosis	1.54e-05	8.36e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—RAP1A—osteoporosis	1.54e-05	8.35e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—OXCT1—osteoporosis	1.53e-05	8.32e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—CA2—osteoporosis	1.53e-05	8.32e-05	CbGpPWpGaD
Vincristine—ABCG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.52e-05	8.29e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—TPI1—osteoporosis	1.5e-05	8.18e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—TPI1—osteoporosis	1.49e-05	8.11e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—MGLL—osteoporosis	1.49e-05	8.1e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PGLS—osteoporosis	1.48e-05	8.07e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GPD2—osteoporosis	1.48e-05	8.07e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—ENO1—osteoporosis	1.48e-05	8.06e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.47e-05	7.98e-05	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—MYC—osteoporosis	1.46e-05	7.95e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—PSMA2—osteoporosis	1.46e-05	7.94e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—PSMA5—osteoporosis	1.46e-05	7.94e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—P4HB—osteoporosis	1.41e-05	7.69e-05	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—MYC—osteoporosis	1.4e-05	7.64e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—P4HB—osteoporosis	1.4e-05	7.62e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—GAPDH—osteoporosis	1.39e-05	7.55e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—CYP19A1—osteoporosis	1.38e-05	7.49e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—GAPDH—osteoporosis	1.37e-05	7.48e-05	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—MYC—osteoporosis	1.37e-05	7.47e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—CALCA—osteoporosis	1.36e-05	7.4e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PNP—osteoporosis	1.36e-05	7.38e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—ATIC—osteoporosis	1.36e-05	7.38e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—RAP1A—osteoporosis	1.35e-05	7.35e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—RAP1A—osteoporosis	1.34e-05	7.29e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.34e-05	7.28e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—CYP19A1—osteoporosis	1.32e-05	7.19e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—IDH2—osteoporosis	1.27e-05	6.89e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—CYP19A1—osteoporosis	1.27e-05	6.89e-05	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—MYC—osteoporosis	1.26e-05	6.83e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—ENO1—osteoporosis	1.24e-05	6.75e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—KL—osteoporosis	1.24e-05	6.72e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PSMA5—osteoporosis	1.22e-05	6.65e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PSMA2—osteoporosis	1.22e-05	6.65e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—CYP27A1—osteoporosis	1.19e-05	6.48e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ACP5—osteoporosis	1.16e-05	6.3e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—OXCT1—osteoporosis	1.15e-05	6.28e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CA2—osteoporosis	1.15e-05	6.28e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—ADCY5—osteoporosis	1.13e-05	6.12e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—MGLL—osteoporosis	1.12e-05	6.12e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—GPX1—osteoporosis	1.12e-05	6.1e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—ENO1—osteoporosis	1.09e-05	5.94e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—ENO1—osteoporosis	1.08e-05	5.89e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—ADCY5—osteoporosis	1.08e-05	5.87e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—TPI1—osteoporosis	1.08e-05	5.86e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PSMA2—osteoporosis	1.08e-05	5.85e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PSMA5—osteoporosis	1.08e-05	5.85e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—GPX1—osteoporosis	1.08e-05	5.85e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PSMA2—osteoporosis	1.07e-05	5.8e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PSMA5—osteoporosis	1.07e-05	5.8e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—MTHFR—osteoporosis	1.04e-05	5.63e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—ADCY5—osteoporosis	1.03e-05	5.63e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—GPX1—osteoporosis	1.03e-05	5.61e-05	CbGpPWpGaD
Vincristine—CYP3A4—Biological oxidations—POMC—osteoporosis	1.02e-05	5.56e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—P4HB—osteoporosis	1.01e-05	5.51e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MYC—osteoporosis	1.01e-05	5.5e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TGFB1—osteoporosis	1.01e-05	5.48e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—GAPDH—osteoporosis	9.94e-06	5.41e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—MTHFR—osteoporosis	9.93e-06	5.4e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—CYP19A1—osteoporosis	9.92e-06	5.4e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—ADCY5—osteoporosis	9.68e-06	5.27e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—RAP1A—osteoporosis	9.68e-06	5.27e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PKM—osteoporosis	9.64e-06	5.24e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—FDPS—osteoporosis	9.64e-06	5.24e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—IDH2—osteoporosis	9.56e-06	5.2e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—MTHFR—osteoporosis	9.52e-06	5.18e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PGLS—osteoporosis	9.14e-06	4.97e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GPD2—osteoporosis	9.14e-06	4.97e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CYP27A1—osteoporosis	8.99e-06	4.89e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—MTHFR—osteoporosis	8.9e-06	4.84e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	8.82e-06	4.8e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	8.8e-06	4.79e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—ACP5—osteoporosis	8.74e-06	4.76e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—CYP19A1—osteoporosis	8.73e-06	4.75e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—CYP19A1—osteoporosis	8.65e-06	4.71e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—IRS2—osteoporosis	8.47e-06	4.61e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ATIC—osteoporosis	8.36e-06	4.55e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PNP—osteoporosis	8.36e-06	4.55e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—POMC—osteoporosis	8.28e-06	4.5e-05	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.23e-06	4.48e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	8.21e-06	4.47e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—TPI1—osteoporosis	8.13e-06	4.42e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—ADCY5—osteoporosis	8.11e-06	4.41e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—GPX1—osteoporosis	8.08e-06	4.4e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—POMC—osteoporosis	7.94e-06	4.32e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ENO1—osteoporosis	7.83e-06	4.26e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PSMA2—osteoporosis	7.71e-06	4.19e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PSMA5—osteoporosis	7.71e-06	4.19e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—P4HB—osteoporosis	7.64e-06	4.16e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—POMC—osteoporosis	7.61e-06	4.14e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—IL6—osteoporosis	7.59e-06	4.13e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GAPDH—osteoporosis	7.5e-06	4.08e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—MTHFR—osteoporosis	7.46e-06	4.06e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—IRS1—osteoporosis	7.39e-06	4.02e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—RAP1A—osteoporosis	7.3e-06	3.97e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—ADCY5—osteoporosis	7.13e-06	3.88e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—GPX1—osteoporosis	7.11e-06	3.87e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—OXCT1—osteoporosis	7.11e-06	3.87e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CA2—osteoporosis	7.11e-06	3.87e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—ADCY5—osteoporosis	7.07e-06	3.85e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—GPX1—osteoporosis	7.05e-06	3.83e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—IL6R—osteoporosis	6.95e-06	3.78e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—MGLL—osteoporosis	6.93e-06	3.77e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—MTHFR—osteoporosis	6.56e-06	3.57e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—MTHFR—osteoporosis	6.5e-06	3.54e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—CYP19A1—osteoporosis	6.26e-06	3.4e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—POMC—osteoporosis	5.96e-06	3.24e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—ENO1—osteoporosis	5.9e-06	3.21e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—IDH2—osteoporosis	5.89e-06	3.2e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PSMA5—osteoporosis	5.82e-06	3.17e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PSMA2—osteoporosis	5.82e-06	3.17e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CYP27A1—osteoporosis	5.54e-06	3.01e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ACP5—osteoporosis	5.39e-06	2.93e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—POMC—osteoporosis	5.25e-06	2.85e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—POMC—osteoporosis	5.2e-06	2.83e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ADCY5—osteoporosis	5.11e-06	2.78e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—GPX1—osteoporosis	5.09e-06	2.77e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—TPI1—osteoporosis	5.01e-06	2.72e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CYP19A1—osteoporosis	4.72e-06	2.57e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—P4HB—osteoporosis	4.71e-06	2.56e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—MTHFR—osteoporosis	4.7e-06	2.56e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GAPDH—osteoporosis	4.62e-06	2.51e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—RAP1A—osteoporosis	4.5e-06	2.45e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—MYC—osteoporosis	4.12e-06	2.24e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—TGFB1—osteoporosis	4.11e-06	2.23e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—ADCY5—osteoporosis	3.86e-06	2.1e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GPX1—osteoporosis	3.84e-06	2.09e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—POMC—osteoporosis	3.76e-06	2.05e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ENO1—osteoporosis	3.64e-06	1.98e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PSMA5—osteoporosis	3.58e-06	1.95e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PSMA2—osteoporosis	3.58e-06	1.95e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—MTHFR—osteoporosis	3.55e-06	1.93e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—IL6—osteoporosis	3.09e-06	1.68e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CYP19A1—osteoporosis	2.91e-06	1.58e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—POMC—osteoporosis	2.84e-06	1.54e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ADCY5—osteoporosis	2.38e-06	1.29e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GPX1—osteoporosis	2.37e-06	1.29e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—MTHFR—osteoporosis	2.19e-06	1.19e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—POMC—osteoporosis	1.75e-06	9.51e-06	CbGpPWpGaD
